Effects of a selective PPARα modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model-Reference-Cited by-同舟云学术

Effects of a selective PPARα modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model

Published:2022-10 Issue: Volume:625 Page:116-121
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Ohkoshi-Yamada Marina,Kamimura Kenya^ORCID,Kimura Atsushi,Tanaka Yuto,Nagayama Itsuo,Yakubo Shunta,Abe Hiroyuki,Yokoo Takeshi^ORCID,Sakamaki Akira,Kamimura Hiroteru,Terai Shuji

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference30 articles.

1. Non-alcoholic fatty liver disease: current global burden;El-Kassas;Semin. Liver Dis.,2022

2. Mechanisms and disease consequences of nonalcoholic fatty liver disease;Loomba;Cell,2021

3. Complications, morbidity and mortality of nonalcoholic fatty liver disease;Mantovani;Metabolism,2020

4. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients;Targher;Diabetes,2005

5. Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease;Mantovani;Dig. Dis. Sci.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitors: how do they affect the cardiac cells;Molecular and Cellular Biochemistry;2024-08-19

2. PPARs/macrophages: A bridge between the inflammatory response and lipid metabolism in autoimmune diseases;Biochemical and Biophysical Research Communications;2023-12